Thea D' Ambrosio

Array ( [id] => 11046289 [patent_doc_number] => 20160243248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'GLYCOTARGETING THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/859292 [patent_app_country] => US [patent_app_date] => 2015-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30774 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12999925 [patent_doc_number] => 10023620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Methods for treatment of nephrotic syndrome and related conditions [patent_app_type] => utility [patent_app_number] => 14/855060 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 86 [patent_no_of_words] => 27292 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17783604 [patent_doc_number] => 11406709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Therapeutic and research application of PDCL3 [patent_app_type] => utility [patent_app_number] => 15/510965 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 44 [patent_no_of_words] => 51390 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12009692 [patent_doc_number] => 09802998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Short peptide-based therapeutic agent and medicinal composition including the same for inhibiting activities of cancer cells' [patent_app_type] => utility [patent_app_number] => 14/841725 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8154 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16734485 [patent_doc_number] => 10960106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Tissue repair material [patent_app_type] => utility [patent_app_number] => 14/838545 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13089 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12143819 [patent_doc_number] => 09878058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'SHK-based pharmaceutical compositions and methods of manufacturing and using the same' [patent_app_type] => utility [patent_app_number] => 14/836700 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 12454 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11850266 [patent_doc_number] => 20170224759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 15/502060 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13485 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16549743 [patent_doc_number] => 10882892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Channelrhodopsin variants and uses thereof [patent_app_type] => utility [patent_app_number] => 14/817335 [patent_app_country] => US [patent_app_date] => 2015-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18736 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14817335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10705476 [patent_doc_number] => 20160051623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/817648 [patent_app_country] => US [patent_app_date] => 2015-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9419 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14817648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11942104 [patent_doc_number] => 20170246255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Stable Analogs of Peptide and Polypeptide Therapeutics' [patent_app_type] => utility [patent_app_number] => 14/808121 [patent_app_country] => US [patent_app_date] => 2015-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21135 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14808121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11414446 [patent_doc_number] => 09561256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-07 [patent_title] => 'LLP2A-bisphosphonate conjugates for osteoporosis treatment' [patent_app_type] => utility [patent_app_number] => 14/806398 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 41 [patent_no_of_words] => 21260 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14806398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10728315 [patent_doc_number] => 20160074465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'Methods for Treating Hypotension' [patent_app_type] => utility [patent_app_number] => 14/794102 [patent_app_country] => US [patent_app_date] => 2015-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8938 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14794102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10729600 [patent_doc_number] => 20160075750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'Production of TSG-6 Protein' [patent_app_type] => utility [patent_app_number] => 14/793086 [patent_app_country] => US [patent_app_date] => 2015-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16410 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11009747 [patent_doc_number] => 20160206701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'Formulation comprising a stabilized complex of corticotropin releasing hormone and alpha-2 macroglobulin' [patent_app_type] => utility [patent_app_number] => 14/792608 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8208 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11567451 [patent_doc_number] => 20170106096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'HOMOGENOUS ANTIBODY DRUG CONJUGATES VIA ENZYMATIC METHODS' [patent_app_type] => utility [patent_app_number] => 15/317907 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23116 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11568909 [patent_doc_number] => 20170107553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'CELL CULTURE PROCESS FOR PRODUCING A PROTEIN' [patent_app_type] => utility [patent_app_number] => 15/315778 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7361 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14294441 [patent_doc_number] => 10287337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents [patent_app_type] => utility [patent_app_number] => 14/727589 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27606 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11713619 [patent_doc_number] => 20170182117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC\nSMALL MOLECULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/313833 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 124743 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367090 [patent_doc_number] => 20150252095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'APOLIPOPROTEIN AIV AS AN ANTIDIABETIC PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/704418 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6929 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122008 [patent_doc_number] => 20160318982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD FOR PREPARING SINGLE-VALENT, MODIFIED AVIDIN-LIKE MOLECULES AND MODIFIED FUNCTIONAL CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/699671 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12124 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699671 [rel_patent_id] =>[rel_patent_doc_number] =>)